Legislators heard public testimony in both the House and Senate on expanded patient access to medication used to treat opioid addiction.

HB 2335, sponsored by Rep. Lauren Davis (D–Shoreline), and companion SB 6086, sponsored by Sen. Bob Hasegawa (D–Seattle), allow a health care entity to administer, dispense, or deliver up to a two-week supply of medication to a patient receiving evidence-based opioid use disorder treatment. This is an increase from the previous limit of 72 hours.

Dates to remember

HB 2335 is scheduled for executive session in the House Health Care & Wellness Committee at 8 am on Friday, January 31.